Vanda Pharmaceuticals (NASDAQ:VNDA) Receives New Coverage from Analysts at StockNews com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Vanda Pharmaceuticals (NASDAQ:VNDA) Downgraded to Buy at StockNews com kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
StockNews.com started coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Get Rating) in a report released on Thursday morning. The brokerage issued a strong-buy rating on the biopharmaceutical company’s stock. Vanda Pharmaceuticals Trading Up 1.5 % NASDAQ VNDA opened at $6.20 on Thursday. The firm has a market cap of $356.13 million, a price-to-earnings ratio […]
KBC Group NV lessened its holdings in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Rating) by 49.6% during the 2nd quarter, Holdings Channel reports. The firm owned 5,483 shares of the biopharmaceutical company’s stock after selling 5,389 shares during the period. KBC Group NV’s holdings in Vanda Pharmaceuticals were worth $60,000 as of its […]